nandrolone decanoate (Sarcomed)

N/A

Report date: 2025/01/26 18:26:03
NME

Base Information

Drug Namenandrolone decanoate (Sarcomed)
Drug Alias Namenandrolone decanoate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid agonists
TargetsUpdating
Therapy Area/IndicationsBecker muscular dystrophyMuscular Dystrophy, FacioscapulohumeralMuscular Dystrophy, Duchenne +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSarcomed AB
China Registration ClassN/A

Develop Information

Active CompaniesSarcomed AB
Inactive CompaniesN/A
Active IndicationsBecker muscular dystrophyMuscular Dystrophy, FacioscapulohumeralMuscular Dystrophy, Duchenne +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A